Skip to main content
. 2023 Apr 25;149(11):8557–8571. doi: 10.1007/s00432-023-04745-8

Table 1.

Demographics and clinicopathological characteristics of patients

Clinicopathological characteristics Noninvasive (AAH + AIS) Minimally invasive (MIA) Invasive (IA) P value (χ2) P value (Linear correlation)
N 258 125 (48.4) 59 (22.9) 74 (28.7)
Sex

Male

Female

106 (41.1)

152 (58.9)

40 (32.0)

85 (68.0)

25 (42.4%)

34 (57.6%)

41 (55.4%)

33 (44.6%)

0.005** 0.001***
Age, year

Median

Range

53

20–77

50

20–74

53

27–77

58

37–74

 < 0.001***  < 0.001***
Smoking

Yes

Never

63 (24.4)

195 (75.6)

21 (16.8)

104 (83.2)

10 (16.9)

49 (83.1)

32 (43.2)

42 (56.8)

 < 0.001***  < 0.001***
Nodule number

Single

Multiple

163 (63.2)

95 (36.8)

84 (67.2)

41 (32.8)

37 (62.7)

22 (37.3)

42 (56.8)

32 (43.2)

0.335 0.145
Nodule location

Left upper lobe

Left lower lobe

Right upper lobe

Right middle lobe

Right lower lobe

75 (29.1)

44 (17.1)

74 (28.7)

17 (6.6)

48 (18.6)

39 (31.2)

21 (16.8)

35 (28.0)

8 (6.4)

22 (17.6)

17 (28.8)

9 (15.3)

16 (27.1)

4 (6.8)

13 (22.0)

19 (25.7)

14 (18.9)

23 (31.1)

5 (6.8)

13 (17.6)

0.993 0.612
Nodule type

Nonsolid or ground-glass opacity (GGNs)

Part-solid (PSNs)

Solid or Soft tissue density (SNs)

Cystic lesions

126 (49.2)

81 (31.6)

46 (18.0)

3 (1.2)

85 (68.5)

31 (25.0)

6 (4.8)

2 (1.6)

30 (50.8)

22 (37.3)

7 (11.9)

0

11 (15.1)

28 (38.4)

33 (45.2)

1 (1.4)

 < 0.001***  < 0.001***
Lesion diameter (cm)

 ≤ 1

1.1–2

174 (67.4)

84 (32.6)

101 (80.8)

24 (19.2)

49 (83.1)

10 (16.9)

24 (32.4)

50 (67.6)

 < 0.001***  < 0.001***
Nodule size (cm)

 ≤ 1

1.1–2

2 < 

147 (57.0)

86 (33.3)

25 (9.7)

89 (71.2)

36 (28.8)

0

42 (71.2)

16 (27.1)

1 (1.7)

16 (21.6)

34 (45.9)

24 (32.4)

 < 0.001***  < 0.001***

AAH atypical adenomatous hyperplasia, AIS adenocarcinoma in situ, IPA invasive pulmonary adenocarcinoma, MIA minimally invasive adenocarcinoma

P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001